{"title": "PDF", "author": "PDF", "url": "https://infektiologie.co.at/wp-content/uploads/2020/03/9_aberle_live-impftag-14-03-20.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": "Center for Virology  Judith Aberle  \n1 Das neue Coronavirus -          \nwie einzuordnen? \u2013 \nAussicht auf Impfung?  \nAssoz . Prof.  Dr. Judith Aberle  \nZentrum  f\u00fcr Virologie  \n11. Nieder\u00f6sterreichischer Impftag  \n14. M\u00e4rz 2020  China alerts outbreak of viral pneumonia in the central \ncity of Wuhan Dec 2019  \nWuhan, Hubei , China.  \n2 Center for Virology  Judith Aberle  \nCoronavirus may have originated from Wuhan market  \nCoronavirus may have originated from  \nSeafood and fresh food market in Wuhan, Hubei, China.  \n \n3 Center for Virology  Judith Aberle  \nOrigin for SARS -Coronavirus -2 \n10 Jan 2020  \n4 Center for Virology  Judith Aberle  Natural reservoir  and transmission  of coronaviruses  \n5 Center for Virology  Judith Aberle  \nSARS  MERS  Specific  tests  to detect  novel  coronavirus  \nCenter for Virology  Judith Aberle  \n6 \u20227 Jan : New virus  identified  \n\u202210 Jan : Sequence  publicly  available  online  \n \n \n \n \n \n\u202215 Jan: Realtime PCR for nCoV , Charit\u00e9, Berlin, Germany  \n\u202220 Jan : Realtime -PCR established , Center for Virology , Vienna  \n \n \n \n \nIllness onset of patients with confirmed 2019 -nCoV \ninfection  \n7 Center for Virology  Judith Aberle  \n10 Jan 2020  \n8 Center for Virology  Judith Aberle  21 Jan 2020  \nNovel Coronavirus  \nSITUATION REPORT -1  \n21 January 2020  Symptoms: Wuhan University Hospital - Jan 1 -28  \n9 Center for Virology  Judith Aberle  \n\u2022138 patients: 22 -92 years  \n\u2022Fever 99%  \n\u2022Dry cough 59%  \n\u2022Myalgia 35%  \n\u2022Dyspnoe  31% \n\u2022Diarrhoe , Nausea, abdominal pain 10%  \n\u2022ICU 26% (10 days after onset)  \n\u2022ARDS, arrhythmia, shock  \n\u2022Median age 66yrs ; comorbidities 72%  \n\u20226 patients (4.3%) died, 11 still at the ICU  \n\u2022Nosokomial  infection 41%  \n\u202240 (29%) Medical staff  \n\u202217 (12%) hospitalized patients  \n \n \n \nWang D, et al, JAMA Feb 2020  Symptoms: Wuhan University Hospital - Jan 1 -28  \n10 Center for Virology  Judith Aberle  \nZhe Xu, et al, Lancet Respir  Med  Feb 2020  \u2022138 patients: 22 -92 years  \n\u2022Fever 99%  \n\u2022Dry cough 59%  \n\u2022Myalgia 35%  \n\u2022Dyspnoe 31%  \n\u2022Diarrhoe, Nausea, abdominal pain 10%  \n\u2022ICU 26% (10 days after onset)  \n\u2022ARDS, arrhythmia, shock  \n\u2022Median age 66yrs ; comorbidities 72%  \n\u20226 patients (4.3%) died, 11 still at the ICU  \n\u2022Nosokomial infection 41%  \n\u202240 (29%) Medical staff  \n\u202217 (12%) hospitalized patients  \n \n \n China : 1716 confirmed cases of health care workers including \nsix deaths.  \n \n11 Center for Virology  Judith Aberle  WHO  Situation Report 14 Feb 2020  \n \n12 Center for Virology  Judith Aberle  \n \n \n \n \n          \n \n \n              \nDays of illness   \nIdentification  \nIsolation  Identification  \nIsolation  SARS -1 Influenza  \nVaccine  \nTherapy  1         10         20  1                5  Virus excretion pattern  30 Jan 2020  \n13 Center for Virology  Judith Aberle  \nCoronavirus global health emergency by WHO  \nSITUATION REPORT - 31 January 2020  \n \nTransmission of 2019 -nCoV Infection from an \nAsymptomatic Contact in Germany  \n1 Feb 2020  \n14 Center for Virology  Judith Aberle  \n15 Center for Virology  Judith Aberle  \npercentage\n<9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+051015\nAge (years)\n       Case number       416        549      3619     7600     8571   10.008    8583     3918     140814.8\n8\n3.6\n1.30.4 0.2 0.2 0.1Case fatality rate in China source  China CDC  \n \n Summary of COVID -19 cases \u2013 China CDC  \n\u202272.314 patients  \n \n \n11 Feb 2020.         male:2.8% - female:1.7%  16 Center for Virology  Judith Aberle           Cruise ship quarantined \u2013 Japan, 4 Feb  \n4-19 Feb 2020  \nQuarantine  \n21.1 4.2. 621 \n19.2.  Total confirmed : 696  \n                      7 deaths  17 Center for Virology  Judith Aberle  Countries, territories or areas with reported confirmed cases of COVID -19, \n12 March 2020  \n18 Center for Virology  Judith Aberle  63 74 \n6 \n133 17 \n4 44 68 \n20 Vbg Tirol  Sbg O\u00d6 N\u00d6 \nWien  \nBgld  \nKtn Stmk  Coronavirus  COVID -19 F\u00e4lle in \u00d6sterreich  \nAnzahl der F\u00e4lle nach Bundesland \u2013 gesamt 428: Stand : 13.3 . 2020  \n0100020003000400050006000\n050100150200250300350400450500\n23.2.\n25.2.\n27.2.\n28.2.\n1.3.\n3.3.\n5.3.\n7.3.\n9.3.\n11.3.\nANZAHL TESTUNGEN \u00d6STERREICH  COVID -19 POSITIVE  \nIdentifizierte F\u00e4lle und Anzahl der Testungen  19 Center for Virology  Judith Aberle          Coronavirus   \n \nWrapp , et al, Science Feb 2020  Umh\u00fcllte Viren mit nicht segmentiertem RNA -genom  Membrane  \nProtein (M)  Nucleocapsid  protein  (N) \nSpike \nprotein  (S) \nEnvelope  \nprotein  (E) \nRNA  \nSpike protein  (S) Vaccine candidates for SARS, MERS, COVID -19 \n20 Center for Virology  Judith Aberle  Spike glycoprotein  is the target  of most  vaccine  candidates  \n    2003  2004  2012  2015  2016  2020  SARS \noutbreak  MERS  \nfirst outbreak   \nin Saudi Arabia  \nHuman phase  I \n \n\u2022Inactivated  (Sinuvac ) \n\u2022DNA vaccine  (NIH)  MVA -MERS \nvaccine  \n(Biologica ) MERS DNA \nvaccine  \n(Inovio ) \n SARS -2 \nfirst outbreak   \nin China  \n2019  \nMERS \nChAdOx1 \n(Oxford)  \nWHO Vaccine  prioritization  for SARS -CoV-2 \nfor clinical  trials  \n21 Center for Virology  Vaccine platforms technologies  \n\u2022Nucleic acids: DNA ( Inovio , Barda /Sanofi), mRNA ( Moderna , CureVac ) \n\u2022Viral vectored vaccines: Ad/ ChAd , MVA, VSV  \n\u2022Inactivated vaccine (HKU)  \n\u2022Protein Subunit - Full-length S trimers - nanoparticle ( Novavax ) \n    \n \n \nJudith Aberle  ", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}